Shares of CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares.
CardioGenics Stock Down 100.0 %
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
See Also
- Five stocks we like better than CardioGenics
- Why Are These Companies Considered Blue Chips?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- Best Stocks Under $5.00
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
